{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:46:35Z","timestamp":1790034395595,"version":"4.0.1"},"reference-count":53,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82073853"],"award-info":[{"award-number":["82073853"]}]},{"name":"National Natural Science Foundation of China","award":["82141204"],"award-info":[{"award-number":["82141204"]}]},{"name":"National Natural Science Foundation of China","award":["2021-I2M-1-005"],"award-info":[{"award-number":["2021-I2M-1-005"]}]},{"name":"National Natural Science Foundation of China","award":["2022-I2M-JB-010"],"award-info":[{"award-number":["2022-I2M-JB-010"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["82073853"],"award-info":[{"award-number":["82073853"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["82141204"],"award-info":[{"award-number":["82141204"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2021-I2M-1-005"],"award-info":[{"award-number":["2021-I2M-1-005"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2022-I2M-JB-010"],"award-info":[{"award-number":["2022-I2M-JB-010"]}]}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["IJMS"],"abstract":"<jats:p>There is a new form of puerarin, puerarin-V, that has recently been developed, and it is unclear whether puerarin-V has a cardioprotective effect on diabetic cardiomyopathy (DCM). Here, we determined whether puerarin-V had any beneficial influence on the pathophysiology of DCM and explored its possible mechanisms. By injecting 30 mg\/kg of STZ intraperitoneally, diabetes was induced in rats. After a week of stability, the rats were injected subcutaneously with ISO (5 mg\/kg). We randomly assigned the rats to eight groups: (1) control; (2) model; (3) metformin; (4\u20136) puerarin-V at different doses; (7) puerarin (API); (8) puerarin injection. DCM rats were found to have severe cardiac insufficiency (arrythmia, decreased LVdP\/dt, and increased E\/A ratio). In addition, cardiac injury biomarkers (cTn-T, NT-proBNP, AST, LDH, and CK-MB), inflammatory cytokines (IL-1\u03b2, IL-18, IL-6, and TNF-\u03b1), and oxidative damage markers (MDA, SOD and GSH) were markedly increased. Treatment with puerarin-V positively adjusts these parameters mentioned above by improving cardiac function and mitochondrial respiration, suppressing myocardial inflammation, and maintaining the structural integrity of the cardiac muscle. Moreover, treatment with puerarin-V inhibits the P2X7 receptor-mediated pyroptosis pathway that was upregulated in diabetic hearts. Given these results, the current study lends credence to the idea that puerarin-V can reduce myocardial damage in DCM rats. Furthermore, it was found that the effect of puerarin-V in diabetic cardiomyopathy is better than the API, the puerarin injection, and metformin. Collectively, our research provides a new therapeutic option for the treatment of DCM in clinic.<\/jats:p>","DOI":"10.3390\/ijms232113015","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T20:37:58Z","timestamp":1666903078000},"page":"13015","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Puerarin-V Improve Mitochondrial Respiration and Cardiac Function in a Rat Model of Diabetic Cardiomyopathy via Inhibiting Pyroptosis Pathway through P2X7 Receptors"],"prefix":"10.3390","volume":"23","author":[{"given":"Shuchan","family":"Sun","sequence":"first","affiliation":[{"name":"State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China"},{"name":"Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awaguli","family":"Dawuti","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China"},{"name":"Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Difei","family":"Gong","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China"},{"name":"Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6573-4609","authenticated-orcid":false,"given":"Ranran","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China"},{"name":"Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Yuan","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China"},{"name":"Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoubao","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China"},{"name":"Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Xing","sequence":"additional","affiliation":[{"name":"Beijing Key Laboratory of Polymorphic Drugs, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Lu","sequence":"additional","affiliation":[{"name":"Beijing Key Laboratory of Polymorphic Drugs, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanhua","family":"Du","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China"},{"name":"Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianhua","family":"Fang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China"},{"name":"Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","article-title":"IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040","volume":"128","author":"Ogurtsova","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jdiacomp.2015.04.004","article-title":"Glucagon-like peptide 1 receptor agonist (GLP-1 RA): Long-term effect on kidney function in patients with type 2 diabetes","volume":"29","author":"Hansen","year":"2015","journal-title":"J. Diabetes Complicat."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.mayocp.2013.05.022","article-title":"Association of dysglycemia and all-cause mortality across the spectrum of coronary artery disease","volume":"88","author":"Yang","year":"2013","journal-title":"Mayo Clin. Proc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1016\/j.ijcard.2013.06.143","article-title":"Epidemiology of typical coronary heart disease versus heart disease of uncertain etiology (atypical) fatalities and their relationships with classic coronary risk factors","volume":"168","author":"Menotti","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1007\/s12325-021-01711-z","article-title":"Advances in Clinical Cardiology 2020: A Summary of Key Clinical Trials","volume":"38","author":"Kearney","year":"2021","journal-title":"Adv. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pharmthera.2014.01.003","article-title":"Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways","volume":"142","author":"Huynh","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1900\/RDS.2006.3.108","article-title":"Causes and Characteristics of Diabetic Cardiomyopathy","volume":"3","author":"Wang","year":"2006","journal-title":"Rev. Diabet. Stud."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2042018819834869","DOI":"10.1177\/2042018819834869","article-title":"Diabetic cardiomyopathy: Prevalence, determinants and potential treatments","volume":"10","author":"Gulsin","year":"2019","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCULATIONAHA.106.680157","article-title":"Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes","volume":"116","author":"Boodhwani","year":"2007","journal-title":"Circulation"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.3389\/fphar.2019.01535","article-title":"Assessment of the Preventive Effect Against Diabetic Cardiomyopathy of FGF1-Loaded Nanoliposomes Combined With Microbubble Cavitation by Ultrasound","volume":"10","author":"Zheng","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1475-2840-12-44","article-title":"Early cardiac changes in a rat model of prediabetes: Brain natriuretic peptide overexpression seems to be the best marker","volume":"12","author":"Nunes","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Filardi, T., Ghinassi, B., Di Baldassarre, A., Tanzilli, G., Morano, S., Lenzi, A., Basili, S., and Crescioli, C. (2019). Cardiomyopathy Associated with Diabetes: The Central Role of the Cardiomyocyte. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20133299"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/s41419-018-1029-4","article-title":"Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy","volume":"9","author":"Yang","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1159\/000494576","article-title":"LncRNA KCNQ1OT1 Mediates Pyroptosis in Diabetic Cardiomyopathy","volume":"50","author":"Yang","year":"2018","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/jcsm.12662","article-title":"Amelioration of diabetes-induced inflammation mediated pyroptosis, sarcopenia, and adverse muscle remodelling by bone morphogenetic protein-7","volume":"12","author":"Singla","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Dessouki, F., Kukreja, R., and Singla, D. (2020). Stem Cell-Derived Exosomes Ameliorate Doxorubicin-Induced Muscle Toxicity through Counteracting Pyroptosis. Pharmaceuticals, 13.","DOI":"10.3390\/ph13120450"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.272.5262.735","article-title":"The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7)","volume":"272","author":"Surprenant","year":"1996","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fncel.2014.00006","article-title":"Principles and properties of ion flow in P2X receptors","volume":"8","author":"Samways","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3109\/0886022X.2015.1011500","article-title":"The Puerarin improves renal function in STZ-induced diabetic rats by attenuating eNOS expression","volume":"37","author":"Zhang","year":"2015","journal-title":"Ren. Fail."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4545321","DOI":"10.1155\/2018\/4545321","article-title":"Puerarin Mitigates Diabetic Hepatic Steatosis and Fibrosis by Inhibiting TGF\u2014\u03b2 Signaling Pathway Activation in Type 2 Diabetic Rats","volume":"2018","author":"Hou","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/10286020.2017.1405941","article-title":"Puerarin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of inflammation","volume":"21","author":"Yin","year":"2019","journal-title":"J. Asian Nat. Prod. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.7150\/ijbs.29680","article-title":"Metformin Inhibits the NLRP3 Inflammasome via AMPK\/mTOR-dependent Effects in Diabetic Cardiomyopathy","volume":"15","author":"Yang","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3389\/fphys.2020.00425","article-title":"Metformin Ameliorates Diabetic Cardiomyopathy by Activating the PK2\/PKR Pathway","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0306-3623(89)90199-7","article-title":"Isoproterenol-induced ultrastructural alterations in hearts of alloxan-diabetic rabbits","volume":"20","author":"Bhimji","year":"1989","journal-title":"Gen. Pharmacol."},{"key":"ref_25","first-page":"122","article-title":"Changes in levels of lipid peroxides and activity of superoxide dismutase and catalase in diabetes associated with myocardial infarction","volume":"30","author":"Kumar","year":"1992","journal-title":"Indian J. Exp. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1002\/cpz1.78","article-title":"Streptozotocin-Induced Diabetic Models in Mice and Rats","volume":"1","author":"Furman","year":"2021","journal-title":"Curr. Protoc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jacc.2008.04.069","article-title":"Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)","volume":"52","author":"Masson","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1373\/clinchem.2006.069575","article-title":"Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: The Valsartan Heart Failure (Val-HeFT) data","volume":"52","author":"Masson","year":"2006","journal-title":"Clin. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jacc.2011.10.875","article-title":"Chronic hyperglycemia and subclinical myocardial injury","volume":"59","author":"Rubin","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.tox.2006.11.053","article-title":"Preventive effect of naringin on cardiac markers, electrocardiographic patterns and lysosomal hydrolases in normal and isoproterenol-induced myocardial infarction in Wistar rats","volume":"230","author":"Rajadurai","year":"2007","journal-title":"Toxicology"},{"key":"ref_31","first-page":"267","article-title":"Protective effect of scutellarin on myocardial infarction induced by isoprenaline in rats","volume":"21","author":"Huang","year":"2018","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"H927","DOI":"10.1152\/ajpheart.00049.2016","article-title":"Diastolic dysfunction in prediabetic male rats: Role of mitochondrial oxidative stress. American journal of physiology","volume":"311","author":"Koncsos","year":"2016","journal-title":"Heart Circ. Physiol."},{"key":"ref_33","first-page":"38","article-title":"Literature Analysis of 35 Cases of Acute Hemolytic Anemia due to Puerarin","volume":"4","author":"Hong","year":"2008","journal-title":"Tianjin Pharm."},{"key":"ref_34","first-page":"47","article-title":"The importance of pharmaceutical excipients according to the abnormal toxicity of Puerarin","volume":"7","author":"Zhou","year":"2010","journal-title":"China Med. Her."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1136\/heartjnl-2015-307876","article-title":"ST-segment depression resolution predicts infarct size and reperfusion injury in ST-elevation myocardial infarction","volume":"101","author":"Reinstadler","year":"2015","journal-title":"Heart"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/nature01335","article-title":"Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death","volume":"421","author":"Mohler","year":"2003","journal-title":"Nature"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fcvm.2018.00107","article-title":"Genetic Alterations in Oxidant and Anti-Oxidant Enzymes in the Vascular System","volume":"5","author":"Awad","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.atherosclerosis.2013.10.003","article-title":"Coptisine protects rat heart against myocardial ischemia\/reperfusion injury by suppressing myocardial apoptosis and inflammation","volume":"231","author":"Guo","year":"2013","journal-title":"Atherosclerosis"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10741-013-9405-8","article-title":"Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target","volume":"19","author":"Glezeva","year":"2014","journal-title":"Heart Fail. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cbi.2015.11.032","article-title":"Challenges and issues with streptozotocin-induced diabetes\u2014A clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics","volume":"244","author":"Goyal","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fcvm.2020.00012","article-title":"Mitochondrial ROS Formation in the Pathogenesis of Diabetic Cardiomyopathy","volume":"7","author":"Kaludercic","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12933-014-0118-7","article-title":"Cardiac contractile function and mitochondrial respiration in diabetes-related mouse models","volume":"13","author":"Marciniak","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1159\/000374021","article-title":"Exercise Prevents Cardiac Injury and Improves Mitochondrial Biogenesis in Advanced Diabetic Cardiomyopathy with PGC-1\u03b1 and Akt Activation","volume":"35","author":"Wang","year":"2015","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fphar.2020.00256","article-title":"Icariin Ameliorates Diabetic Cardiomyopathy Through Apelin\/Sirt3 Signalling to Improve Mitochondrial Dysfunction","volume":"11","author":"Ni","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12944-018-0872-8","article-title":"Profile of cardiac lipid metabolism in STZ-induced diabetic mice","volume":"17","author":"Li","year":"2018","journal-title":"Lipids Health Dis."},{"key":"ref_46","first-page":"5681081","article-title":"Streptozotocin-Induced Adaptive Modification of Mitochondrial Supercomplexes in Liver of Wistar Rats and the Protective Effect of Moringa oleifera Lam","volume":"2018","year":"2018","journal-title":"Biochem. Res. Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fendo.2019.00202","article-title":"Exenatide Protects Against Cardiac Dysfunction by Attenuating Oxidative Stress in the Diabetic Mouse Heart","volume":"10","author":"Ding","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3389\/fphys.2017.00519","article-title":"NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy","volume":"8","author":"Luo","year":"2017","journal-title":"Front. Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.15252\/embj.201695415","article-title":"Pore formation by GSDMD is the effector mechanism of pyroptosis","volume":"35","author":"Gaidt","year":"2016","journal-title":"EMBO J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/MOL.0b013e328359b0a6","article-title":"Effect of interleukin 1\u03b2 inhibition in cardiovascular disease","volume":"23","author":"Qamar","year":"2012","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"692028","DOI":"10.3389\/fcell.2021.692028","article-title":"P2X7 Receptor Deficiency Ameliorates STZ-induced Cardiac Damage and Remodeling Through PKC\u03b2 and ERK","volume":"9","author":"Huang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Yang, L., Ling, W., Yang, Y., Chen, Y., Tian, Z., Du, Z., Chen, J., Xie, Y., Liu, Z., and Yang, L. (2017). Role of Purified Anthocyanins in Improving Cardiometabolic Risk Factors in Chinese Men and Women with Prediabetes or Early Untreated Diabetes-A Randomized Controlled Trial. Nutrients, 9.","DOI":"10.3390\/nu9101104"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1039\/C3FO60565E","article-title":"Effects of puerarin in STZ-induced diabetic rats by oxidative stress and the TGF-\u03b21\/Smad2 pathway","volume":"5","author":"She","year":"2014","journal-title":"Food Funct."}],"updated-by":[{"DOI":"10.3390\/ijms27146161","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000}}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/21\/13015\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T09:48:28Z","timestamp":1783676908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/21\/13015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":53,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["ijms232113015"],"URL":"https:\/\/doi.org\/10.3390\/ijms232113015","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,27]]}}}